M
Mona Saraiya
Researcher at Centers for Disease Control and Prevention
Publications - 258
Citations - 18861
Mona Saraiya is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Cervical cancer & Population. The author has an hindex of 57, co-authored 247 publications receiving 15391 citations. Previous affiliations of Mona Saraiya include American Society for Clinical Pathology.
Papers
More filters
Journal ArticleDOI
Type-specific HPV and Pap test results among low-income, underserved women: providing insights into management strategies.
Mona Saraiya,Vicki B. Benard,April Greek,Martin Steinau,Sonya Patel,L. Stewart Massad,George F. Sawaya,Elizabeth R. Unger +7 more
TL;DR: Typing for HPV 16/18 appears to assist in the management in a small proportion of women with discordant results, which is similar to those reported throughout the US in a variety of populations.
Journal ArticleDOI
US physicians' intentions regarding impact of human papillomavirus vaccine on cervical cancer screening
TL;DR: Important baseline data on intentions in the period preceding widespread vaccine diffusion is provided and may help explain current and future trends in practice patterns.
Journal ArticleDOI
Trends in the use of cervical cancer screening tests in a large medical claims database, United States, 2013-2019.
TL;DR: In this paper, the authors examined trends in the use of cervical cancer screening tests during 2013-2019 among commercially insured women and assessed trends using 2-sided Poisson regression, showing that use of cytology alone decreased from 34.2% in 2013 to 26.4% in 2019 among women aged 21-29 years.
Journal ArticleDOI
Invasive and in situ cervical cancer reported to the vaccine adverse event reporting system (VAERS).
Charlene A. Wong,Jamie W. Krashin,Alison Rue-Cover,Mona Saraiya,Elizabeth R. Unger,Angela Calugar,Lauri E. Markowitz +6 more
TL;DR: The objective of this study was to identify and review VAERS reports of invasive and in situ cervical cancer in women immunized with the quadrivalent HPV vaccine.